The bullish market with new ATH

 The US stock markets post new records:

• DOW JONES - 30,301.79
• S&P 500 - 3,722.43
• NASDAQ - 12,764.75
• RUSSELL 2000 - 1,978.05 

Dow Jones, S&P 500 post record closing highs

The Dow and S&P 500 hit a record closing highs on Monday after Moderna became the latest major drug-maker to announce upbeat data (94.5% effective in preventing COVID-19 in participants.) building on hopes that an effective vaccination will soon be available.

Pfizer - what the media don't tell you?

Pfizer Inc. corporation - one of the world's largest pharmaceutical companies and ranked 57 on the 2018 Fortune 500 list - is supposed to be Covid-19 game changer after it showed strong results in trials. Stock markets significantly reacted but not only. For instance, only the European Union has agreed to buy up to 300 million doses of the coronavirus vaccine.

That what the media say right now. But there are more interesting stories about Pfizer that are happening now and nobody wants talk about 'not interesting' facts. Within this post, we list a few facts that each investor should catch an eye on Pfizer and German-related company BioNTech that can found in a quarterly securities filing of Pfizer. Here is a list of untold stories:

1) The U.S. Securities and Exchange Commission (SEC) and the Department of Justice (DOJ) are looking into Pfizer's operations in China, Russia and India. Both requests fall under the Foreign Corrupt Practices Act (FCPA), which forbids U.S. firms and individuals from bribing foreign government officials to benefit their businesses. Only in 2012, Pfizer agreed to pay over $60 million to settle charges by the SEC and DOJ for allegedly violating the FCPA.

2)  In March 2020, Pfizer Inc. paid $200 million to California consumers for the alleged off-label marketing of its harmful hormone therapy products. The case was originally filed in December 2003.

3) The U.S. Department of Justice Antitrust Division Investigation investigates not transparent Greenstone generics business which may pursue a suit for the recovery of civil damages and penalties on behalf of the government.

4) Biogen Idec MA Inc. filed patent litigation against Pfizer which is pending in the U.S. District Court for the District of New Jersey and the United States Court of Appeals for the Federal Circuit. Company has acknowledged that it is obligated to satisfy any award of damages.

Last but not least, it is worth to mention that the Pfizer's CEO sold stock worth $5.6 million on same day as COVID-19 vaccine announcement. 

Support for Android 11.0 R (API 30) - WSE Analyzer update!

Dear users and investors,

You can find new update of the Warsaw Stock Exchange Analyzer app available on Google Play. 

As promised before, you can find new companies such as Allegro, Mercator and many more. What is more we support the latest version of the Android 11.0 (API 30). 

Cheers,
fs-team

Allegro prepares the largest Polish IPO

Dear all,

Poland’s biggest ecommerce platform, Allegro, is planned to list on the Warsaw Stock Exchange. What we know now is that the number of shares has been increased by 30.86M to max. 246.86M shares. 

Yesterday, Allegro published the supplement to the prospect in which we can read:  

"The offer met with a positive response from potential investors, but the indicated interest in the offer significantly exceeded initial expectations. Therefore, the issuer and the selling shareholders approved the increase of the maximum number of shares offered in the offer to no more than 190,293,225 existing shares, which means no more than 214,658,285 sold shares and no more than 246,857,143 shares in the offer".

For sure, institutional investors generated a huge demand. Likely, they predict that Allegro will find it place in WIG20 index - not now, but probably after Q4 of 2020.

Let's have a look on details of the prospect and answer major questions:

1) Will they pay a dividend in longterm period? (p.4, p.54)

"The Group will review its dividend policy on an ongoing basis but does not expect to declare or pay any dividends for the foreseeable future."

2) Biggest competitors? (p.8)

Alibaba, Amazon and eBay, but within a prospect we can spot others competitors such as: RTV Euro AGD, Biedronka, Empik, SMYK and LPP, Zalando, eobuwie.pl, Oponeo -- well-known Polish brands. 

3) Does Allegro has a debt? (p.55)

As you can see, the following Table presents that yes, they have a big debt that needed to be paid.

4) What is the ratio between Allegro's comprehensive income vs. financial cost? (p.57)

Net profit + (-(Other comprehensive loss)) - Financial cost = +14.1M

In a nutshell, the following table presents that the Total comprehensive income is almost the same as presented financial cost. Hopefully, it's positive. What is more interesting, the last measured period was not audited via external auditors.

5) When individual investors can assign to buy Allegro's share within IPO?

Between 23-28.09.2020. Acceptance of purchase orders from the Retail Investors (until 11:59 p.m. Warsaw time on September 28, 2020). So, if you want to buy Allegro's shares you can do it till end of Monday.

6) When we can expected first day of trading of the Shares on the Warsaw Stock Exchange?

About 12.10.2020.

7) Will it be available in Warsaw Stock Exchange Analyzer? 

For sure, yes! 

If you don't want to wait for Allegro's IPO you can always download WSE Analyzer from Google Play in order to evaluate conditions of Polish companies listed in Warsaw Stock Exchange.

Unlocking CDPROJEKT RED

Dear users, investors, and gaming community,

Due to a huge volatility that we see on the CD Projekt share, we've decided to unlock the company within the free version of Warsaw Stock Exchange Analyzer. 

The following picture presents how the share has behaved since May 2020. As you can see, we experienced two extreme levels.  Red circles depict the price and Relative Strength Indicator within overbought level. In turn, green circles present oversold level caught to months later.

Fig. 1 Overbought (red circles) and oversold levels (green circles).

Currently, the CD PROJEKT RED share is available to track for free. Only what you need to do is to update the WSE Analyzer Lite from Google Play store. After updating the application, CD PROJEKT RED is available to use in the main menu (WIG20) as presented in Figure 2.

Fig. 2 Overbought (red circles) and oversold levels (green circles).

Why CD Projekt is so played by investors? The answer is the product being in the final stage of production - Cyberpunk 2077. The game is highly anticipated open-world RPG. The publication has been delayed twice. The authors stated that the premiere will take off in November 19th. Hopefully, we stick our thumbs together that it's the final date. The following youtube film presents the newest trailer showcasing the world, characters, story, and action of Cyberpunk 2077.

As you might noticed, we have also unlocked well-know and popular shares such as DINOPL, KGHM, PEKAO and PKNORLEN. If you would like to unlock the rest shares please download the full version of Warsaw Stock Exchange Analyzer from Google Play.

Best regards,

fs-team

19th June - Expiration of futures

Dear all,

Just to remind you, futures will not be valid after a session in 19th June 2020. It means that volatility can be significant higher that day.

You can always watch overbought/oversold levels using Frankfurt Stock Exchange Analyzer and also Warsaw Stock Exchange Analyzer.


Best regards,
fs-team